Basket cover image
15 handpicked stocks

The Alchemists

These innovative companies have mastered the art of turning the overlooked into gold. Carefully selected by our expert analysts, this collection features businesses that create real value from waste materials, industrial byproducts, and untapped resources—transforming the ordinary into extraordinary profits.

stock
stock
stock
stock
stock
stock
stock
stock
stock
stock

+5

Author avatar

Han Tan | Market Analyst

Updated 3 days ago | Published at juin 17

Top Picks from This Group

Here are a few of the assets in this group. Create an account to unlock the full list.

PCT

PURECYCLE TECHNOLOGIES INC

PCT

Current price

$12.21

Its patented technology recycles waste polypropylene into ultra-pure, virgin-like resin.

WCN

Waste Connections, Inc.

WCN

Current price

$185.57

This company generates value from waste streams through recycling and renewable fuels generation.

CWST

Casella Waste Systems Inc

CWST

Current price

$99.00

It operates as a vertically integrated solid waste company with a strong focus on resource renewal and recycling.

About This Group of Stocks

1

Our Expert Thinking

We've identified companies with proven abilities to create treasure from trash—literally. These modern alchemists have developed technologies that transform waste materials, industrial byproducts, and raw data into high-value products, creating profit where others see nothing but cost.

2

What You Need to Know

These companies sit at the intersection of innovation and sustainability, turning environmental challenges into business opportunities. They're positioned to benefit from the global shift toward resource efficiency, circular economies, and waste reduction—trends that are only growing stronger.

3

Why These Stocks

Each company was selected for its specialized technology or process that gives it a competitive edge in resource transformation. They have scalable business models centered on creating value from underutilized or discarded materials, with proven ability to monetize what others consider worthless.

12 Month Growth Potential

Use the growth calculator to see how much investing in these assets could return over one year.

If you invested across these assets:

in 12 months it could be worth:

$1,000.00

+66.00%

Group Performance Snapshot

66%

Average 12 Month Profit

On average, analysts expect assets in this group to grow 66% over the next year.

13 of 14

Stocks Rated Buy by Analysts

13 of 14 assets in this group are rated Buy by professional analysts.

0.5%

Group Growth

This group averaged a 0.5% return last month.

Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.

Why You'll Want to Watch These Stocks

♻️

Tomorrow's Necessities

As regulations tighten on waste and sustainability becomes non-negotiable, these companies aren't just trendy—they're becoming essential to how modern industry operates.

💰

Hidden Value Creators

These companies have figured out how to make money where others see only costs and problems—giving them a unique economic advantage that many investors haven't fully recognized yet.

🔮

Riding the Green Wave

With billions being invested in sustainable solutions worldwide, these resource innovators are perfectly positioned to benefit from one of the biggest economic shifts of our lifetime.

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

The New Cost of Compliance: Investing in HR Tech

The New Cost of Compliance: Investing in HR Tech

Australian airline Qantas received a historic $58 million fine for unlawfully dismissing workers, setting a new precedent for corporate accountability in labor practices. This ruling creates an investment opportunity in companies that provide the essential HR, legal, and compliance technologies businesses now need to navigate stricter labor law enforcement.

View stocks
GLP-1s Target Liver Disease

GLP-1s Target Liver Disease

The FDA's approval of Wegovy for a serious liver disease has boosted Novo Nordisk's market position and highlighted a major new application for GLP-1 drugs. This development creates an investment opportunity in companies focused on innovative treatments for metabolic and liver-related conditions.

View stocks
Pharma's Digital Prescription

Pharma's Digital Prescription

Novo Nordisk is partnering with GoodRx to offer its popular drug Ozempic at a reduced price, boosting GoodRx's stock. This collaboration highlights a growing trend of pharmaceutical companies leveraging digital health platforms to improve drug affordability and expand market reach.

View stocks
View All

Frequently Asked Questions

Everything you need to know about the product and billing.